Upload
joy-walker
View
213
Download
0
Embed Size (px)
Citation preview
Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July 2007 - June 2008 )
Chronic Bowel Disorders3%Antispasmodics
5%Acute Diarrhoea 3%
Drugs Affecting Intestinal Secretions
1%
Dyspepsia & GORD 8%
Ulcer-Healing Drugs 55%
Local Preps for Anal & Rectal Disorders
3%
Laxatives 22%
© Copyright NHSBSA 2008
Pie Chart Showing the Breakdown of Gastro-intestinal Spending in General Practice in England (July 2007 - June 2008)
Ulcer-Healing Drugs 50%
Antispasmodics 6%
Acute Diarrhoea 1%
Local Preps for Anal & Rectal Disorders 2%
Laxatives 13%
Dyspepsia & GORD 5%
Drugs Affecting Intestinal Secretions
5%
Chronic Bowel Disorders18%
© Copyright NHSBSA 2008
Trends in Prescribing of Antacids and simeticone in General Practice in England
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
180,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Co-magaldrox Antacid preparations containing simeticoneSimeticone Magnesium TrisilicateMagnesium oxide Aluminium HydroxideOthers
© Copyright NHSBSA 2008
Trends in Spending on Antacids and simeticone in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
500,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Co-magaldrox Antacid preparations containing simeticoneSimeticone Magnesium TrisilicateMagnesium oxide Aluminium HydroxideOthers
© Copyright NHSBSA 2008
Trends in Prescribing of Compound Alginate Preparations in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Gaviscon Peptac Gastrocote Others
© Copyright NHSBSA 2008
Trends in Spending on Compound Alginate Preparations in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Gaviscon Peptac Gastrocote Others
© Copyright NHSBSA 2008
Trends in Prescribing of Ulcer-healing drugs in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
10,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Proton pump inhibitors H2-receptor antagonists Others
© Copyright NHSBSA 2008
Trends in Spending on Ulcer-healing drugs in General Practice in England
0
20,000,000
40,000,000
60,000,000
80,000,000
100,000,000
120,000,000
140,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Proton pump inhibitors H2-receptor antagonists Others
© Copyright NHSBSA 2008
Trends in Prescribing of and Spending on Helicobacter pylori tests in General Practice in England
0
1,000
2,000
3,000
4,000
5,000
6,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
£0
£20,000
£40,000
£60,000
£80,000
£100,000
£120,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2008
Trends in Prescribing of H2-receptor antagonists in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Ranitidine Cimetidine Nizatidine Famotidine
© Copyright NHSBSA 2008
Trends in Spending on H2-receptor antagonists in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Ranitidine Cimetidine Nizatidine Famotidine
© Copyright NHSBSA 2008
Trends in Prescribing of Proton Pump Inhibitors in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Lansoprazole Omeprazole Esomeprazole Rabeprazole Pantoprazole
© Copyright NHSBSA 2008
Trends in Spending on Proton Pump Inhibitors in General Practice in England
0
20,000,000
40,000,000
60,000,000
80,000,000
100,000,000
120,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Lansoprazole Omeprazole Esomeprazole Rabeprazole Pantoprazole
© Copyright NHSBSA 2008
Trends in Prescribing of Lansoprazole by Strength in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
1,800,000
2,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
30mg cap/tabs 15mg cap/tabs
© Copyright NHSBSA 2008
Trends in Prescribing of Omeprazole by Strength in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
10mg cap/tabs 20mg cap/tabs 40mg cap/tabs
© Copyright NHSBSA 2008
Trends in Prescribing of Aminosalicylates for Inflammatory Bowel Disease in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
500,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Mesalazine Sulfasalazine Olsalazine Balsalazide
© Copyright NHSBSA 2008
Trends in Spending on Aminosalicylates for Inflammatory Bowel Disease in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Mesalazine Sulfasalazine Olsalazine Balsalazide
© Copyright NHSBSA 2008
Trends in Prescribing of Corticosteroids for Inflammatory Bowel Disease in General Practice in England
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Prednisolone Hydrocortisone Budesonide
© Copyright NHSBSA 2008
Trends in Spending on Corticosteroids for Inflammatory Bowel Disease in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
900,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Prednisolone Hydrocortisone Budesonide
© Copyright NHSBSA 2008
Trends in Prescribing of Laxatives in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Osmotic laxatives Stimulant laxatives Bulk-forming laxatives Others
© Copyright NHSBSA 2008
Trends in Spending on Laxatives in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Osmotic laxatives Stimulant laxatives Bulk-forming laxatives Others
© Copyright NHSBSA 2008
Trends in Prescribing of Lactulose Solution in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Qua
ntity
(Litr
es)
© Copyright NHSBSA 2008
Trends in Prescribing of Aspirin (BNF 2.9 & 4.7.1) in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Other Aspirin Formulations E/C
© Copyright NHSBSA 2008
Trends in Prescribing of Aspirin (BNF 2.9 & 4.7.1) in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Aspirin 2.9 Aspirin 4.7.1
© Copyright NHSBSA 2008
Trends in Prescribing of NSAIDs in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Diclofenac Ibuprofen Naproxen Meloxicam Rofecoxib Celecoxib Etoricoxib Others
© Copyright NHSBSA 2008
Trends in Spending on NSAIDs in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08Quarter to
NIC
(£)
Diclofenac Ibuprofen Naproxen Meloxicam Rofecoxib Celecoxib Etoricoxib Others
© Copyright NHSBSA 2008
Trends in Prescribing of Cyclo-oxygenase-2 Selective Inhibitors in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
1,800,000
2,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
Item
s
Meloxicam Rofecoxib Celecoxib Etoricoxib Etodolac Others
© Copyright NHSBSA 2008
Trends in Spending on Cyclo-oxygenase-2 Selective Inhibitors in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
35,000,000
40,000,000
45,000,000
50,000,000
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Quarter to
NIC
(£)
Meloxicam Rofecoxib Celecoxib Etoricoxib Etodolac Others
© Copyright NHSBSA 2008